February 28, 2018 / 8:04 PM / 3 months ago

BRIEF-Daiichi Sankyo Aligns U.S. Commercial Operations To Current Portfolio, Upcoming Cancer Pipeline

Feb 28 (Reuters) - Daiichi Sankyo :

* DAIICHI SANKYO, INC. ALIGNS U.S. COMMERCIAL OPERATIONS TO CURRENT PORTFOLIO AND UPCOMING CANCER PIPELINE

* DAIICHI SANKYO - ‍AS PART OF REORGANIZATION, CO WILL REDUCE HEADCOUNT BY ABOUT 280 EMPLOYEES FROM VARIOUS LOCATIONS IN THE U.S.​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below